Results of a phase III trial investigating copanlisib combined with Rituximab for treatment of relapsed indolent lymphomas. (Abstract only)
Home / Resource Library / CHRONOS-3: Copanlisib plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma